Basic Information
Basic information for LINC00343-290-31aa
Peptide Name LINC00343-290-31aa
Genome Position chr13:105719033-105719125[+]
Species Human
Peptide Sequence MSFCRGLASVFWLLFASLQQIGRQRWESFFQ
Peptide Length 31
Unique No (LINC00343-208-31aa,LINC00343-216-31aa,LINC00343-227-31aa,LINC00343-267-31aa-2,LINC00343-271-31aa,LINC00343-277-31aa,LINC00343-298-31aa,LINC00343-309-31aa,LINC00343-325-31aa)
Grand Average of Hydropathicity 0.2935
Relative Molecular Mass 4280.77
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000667685;LINC00343-290
Transcript Length 1315
Coding Ability 0.4129
DNA Sequence Corresponding to Peptide ATGTCTTTTTGCAGGGGACTAGCTTCAGTATTTTGGCTTCTTTTTGCTTCTTTGCAACAAATTGGGAGACAAAGGTGGGAAAGTTTTTTTCAA
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :